Advertisement

drug discovery

drug discovery

  • Rethink your Impurity Analysis Strategy

Rethink your Impurity Analysis Strategy

, , , , |

In this webinar, Dr. Ejvind Mørtz discusses the benefits and applications of mass spectrometry (MS)-based host cell protein (HCP) analysis and why HCP ELISAs are insufficient for documenting product-related impurities. Watch to learn where to apply the assay in a typical process and what you gain from deploying it to your workflow.

  • Cancer cells

Combination Therapy for Cancer Treatment

News, Scientific Articles|

The combination of anti-cancer drugs, or combination therapy, has been hailed as a “cornerstone of cancer therapy” since it targets key pathways synergistically, thereby enhancing efficacy compared to monotherapies. This blog takes a look at a recent publication in Nature, which reported the effects of 2025 pairwise drug combinations in breast, colon, and pancreatic cell lines.

  • Research Technology & Innovations Summits 2022_FI

Research Technology & Innovation Summits

The 2022 InsideScientific Research Technology & Innovation Summits focus on specific research and therapeutic areas, reviewing how novel technologies and innovative services are advancing discovery in each particular field.

Go to Top